摘要
目的研究分析急性非ST段抬高型心肌梗死急诊患者不同诊疗方式的疗效,评价不同诊疗方式的临床应用价值。方法回顾性分析172例急性非ST段抬高型心肌梗死患者的临床资料,分析不同治疗方式的疗效及对预后的影响。结果PCI组与非PCI组的药物的使用情况差异无统计学意义(P>0.05)。PCI组的临床疗效优于非PCI组,心血管不良事件的发生率及病死率较非PCI组更低(P<0.05)。结论普通药物联合经皮冠状动脉腔内介入治疗是治疗急性非ST段抬高型心肌梗死的有效方法,可明显改善近期预后。
Objective To study the efficacy of different diagnosis and treatment methods in emergency patients with acute non-ST-segment elevation myocardial infarction,and to evaluate the clinical application value of different diagnosis and treatment methods.Methods The clinical data of 172 patients with acute non-ST-segment elevation myocardial infarction were retrospectively analyzed.The efficacy and prognosis of different treatments were analyzed.Results There was no statistically significant difference in the use of drugs between the PCI group and the non-PCI group(P>0.05).The clinical efficacy of the PCI group was better than that of the non-PCI group,and the incidence and mortality of cardiovascular adverse events were lower than those of non-PCI group(P<0.05).Conclusion General drug combined with percutaneous transluminal coronary intervention is an effective treatment for acute non-ST segment myocardial infarction,which can significantly improve the short-term prognosis.
作者
张晶淼
荣阳
ZHANG Jingmiao;RONG Yang(Department of Cardiology,Liaoyang Central Hospital,Liaoning Province,Liaoyang 111000,China;Medical Office,Liaoyang Central Hospital,Liaoning Province,Liaoyang 111000,China)
出处
《中国医药指南》
2021年第28期91-92,共2页
Guide of China Medicine
关键词
心肌梗死
非ST段抬高
介入干预
诊疗分析
Myocardial infarction
Non-ST segment elevation
Interventional intervention
Diagnosis and treatment